Combination of magnetic fluid hyperthermia with inerleukin-2 for treatment of Lewis lung carcinoma in mice

胡润磊,柯贤福,李浒,马胜林,王国卿,魏东山

2014-01-01

Abstract:Objective To investigated the combination of magnetic fluid hyperthermia (MFH) with immunotherapy for treatment of Lewis lung carcinoma in mice. Methods The mouse Lewis lung cancer model was induced by subcutaneous infec-tion of tumor cells, the tumor- bearing mice were divided into 4 groups: control group, IL- 2 group, MFH group and MFH+IL- 2 group when the tumor diameter reached 0.8cm. Magnetic fluids were prepared in vitro and directly injected into tumors. Twen-ty- four hours later, the mice were subjected to an alternating magnetic field. The temperature in the tumor was increased to 43.0℃, which was maintained for 30 min with a stable strength of magnetic field. At 24h after MFH, IL- 2 was injected directly into the tumor in MFH+IL- 2 group. Peripheral CD4+ and CD8+ T- lymphocytes were analyzed by flow cytometry, CD4+, CD8+ and HSP70 in tumors were detected by immunohistochemistry staining. Results Combined magnetic fluid hyperthermia and im-munotherapy significantly inhibited the growth of the tumors(P<0.05). Histological analysis demonstrated that the tumor cells un-derwent apoptosis and necrosis, HSP 70, CD4+and CD8+cells were significant increased after treatment (P<0.05). Conclusion Combined magnetic fluid hyperthermia and immunotherapy can improve the therapeutic efficacy for Lewis lung cancer in mice.